SCHEMBL734090

SCHEMBL734090

CN1CCN(C2(Cc3ccccc3)CCC3(CC2)OCCO3)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
RAD52 P43351 1/20 0.41
MC4R P32245 1/20 0.41
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
POLB P06746 1/20 0.38
SIGMAR1 Q99720 5/20 0.37
OPRM1 P35372 2/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP1 P29466 1/20 0.36
RAB9A P51151 1/20 0.36
CASP7 P55210 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HCN1 O60741 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3218429 0.87 POLB (0.40) KMT2AGAAALDH1A1TSHRL3MBTL1
SCHEMBL3924844 0.86 POLB (0.39) KMT2AGAAALDH1A1TSHRL3MBTL1
SCHEMBL14279644 0.84 GAA (0.55) KMT2AGAARAD52MC4RSIGMAR1
SCHEMBL4124999 0.78 KMT2A (0.44) KMT2AGAARAD52MC4RALDH1A1
SCHEMBL735929 0.77 KMT2A (0.43) KMT2AGAARAD52MC4RSIGMAR1
SCHEMBL13333706 0.75 OPRM1 (0.42) KMT2AGAARAD52MC4RALDH1A1
SCHEMBL4130873 0.74 CYP2D6 (0.43) KMT2AGAARAD52MC4RALDH1A1
SCHEMBL3412905 0.74 GAA (0.46) KMT2AGAARAD52MC4RSIGMAR1
SCHEMBL3208074 0.73 OPRM1 (0.59) GAAALDH1A1TSHRL3MBTL1POLB
SCHEMBL14279693 0.72 KMT2A (0.47) KMT2AGAARAD52MC4RALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 KMT2A 2453/4885GAA 534/4885RAD52 1699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.